Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies

Anita Thyagarajan; Vaibhav Gajjar; Ravi P. Sahu

doi:10.1186/s40779-025-00649-5

Your Location：

Home >

Browse articles >

Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies

REVIEW | Updated：2026-03-26

- Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies
- Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies
- Military Medical Research 2026年13卷第2期页码：267-283
- Affiliations：
  
  Department of Pharmacology and Toxicology, Boonshoft School of Medicine Wright State University, Dayton, OH 45435, USA
- Author bio：
  
  * Anita Thyagarajan anita.thyagarajan@wright.edu
  Ravi P. Sahu ravi.sahu@wright.edu
- Funds：
  
  the National Institutes of Health(RPS;R21 ES033806)
- DOI：10.1186/s40779-025-00649-5
  中图分类号：
- 收稿：2025-02-28，
  
  录用：2025-09-08，
  
  网络首发：2025-09-23，
  
  纸质出版：2026-02
- Accepted：
Scan QR Code
Anita Thyagarajan, Vaibhav Gajjar, Ravi P. Sahu. Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies[J]. Military Medical Research, 2026,13(2):267-283.

Anita Thyagarajan, Vaibhav Gajjar, Ravi P. Sahu. Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies[J]. Military Medical Research, 2026, 13(2): 267-283.
Anita Thyagarajan, Vaibhav Gajjar, Ravi P. Sahu. Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies[J]. Military Medical Research, 2026,13(2):267-283. DOI： 10.1186/s40779-025-00649-5.

Anita Thyagarajan, Vaibhav Gajjar, Ravi P. Sahu. Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies[J]. Military Medical Research, 2026, 13(2): 267-283. DOI： 10.1186/s40779-025-00649-5.

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Impact of targeting the platelet-activating factor and its receptor in cancer treatment

Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies

Applications and prospects of cryo-EM in drug discovery

Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies

Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies

DOI：10.1186/s40779-025-00649-5